Jorge Roig

Jorge Roig

Auto-generated profile, based on publicly available information

Jorge Roig

Department of Pulmonary Medicine, Clínica Creu Blanca, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 January 1994 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
RRRafael Rosell
Rafael Rosell
JGJose Gomez-Codina
Jose Gomez-Codina
CCCarlos Camps
Carlos Camps
JMJose Maestre
Jose Maestre
JPJose Padille
Jose Padille
AAAlbert Abad
Albert Abad
The efficacy of surgery for patients with non-small-cell lung cancer is limited, although recent studies suggest that preoperative chemotherapy may improve survival. We conducted a randomized trial to examine the possible benefit of preoperative chemotherapy and surgery for the treatment of patients with non-small-cell lung cancer.

1 October 1999 in Lung Cancer
Verified
Journal Article
Closed access
RRR Rosell
R Rosell
JGJ Gomezcodina
J Gomezcodina
CCCarlos Camps
Carlos Camps
JJJ Javiersanchez
J Javiersanchez
JMJ Maestre
J Maestre
JRJ Roig
J Roig

23 January 2008 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
JPJordi Almirall Pujol
Jordi Almirall Pujol
IBI. Bolíbar
I. Bolíbar
MSMateu Serra-Prat
Mateu Serra-Prat
JRJ. Roig
J. Roig
IHI. Hospital
I. Hospital
TGthe Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group
the Community-Acquired Pneumonia in Catalan Countries (PACAP) Study Group
The aim of the present study was to identify risk factors for community-acquired pneumonia (CAP), with special emphasis on modifiable risk factors and those applicable to the general population.A population-based, case–control study was conducted, with a target population of 859,033 inhabitants aged >14 yrs. A total of 1,336 patients with confirmed CAP were matched to control subjects by age, sex and primary centre over 1 yr.In the univariate analysis, outstanding risk factors were passive smoking in never-smokers aged >65 yrs, heavy alcohol intake, contact with pets, households with >10 people, contact with children, interventions on the upper airways and poor dental health. Risky treatments included amiodarone,N-acetylcysteine and oral steroids. Influenza and pneumococcal vaccine, and visiting the dentist were protective factors. Multivariable analysis confirmed cigarette smoking, usual contact with children, sudden changes of temperature at work, inhalation therapy (particularly containing steroids and using plastic pear-spacers), oxygen therapy, asthma and chronic bronchitis as independent risk factors.Interventions for reducing community-acquired pneumonia should integrate health habits and lifestyle factors related to household, work and community, together with individual clinical conditions, comorbidities and oral or inhaled regular treatments. Prevention would include vaccination, dental hygiene and avoidance of upper respiratory colonisation.

1 March 2006 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
JRJordi Rello
Jordi Rello
ALEJANDRO HUGO RODRIGUEZ OVIEDOALEJANDRO HUGO RODRIGUEZ OVIEDO
ALEJANDRO HUGO RODRIGUEZ OVIEDO
ATA. Torres
A. Torres
JRJ. Roig
J. Roig
JSJ. Sole-Violan
J. Sole-Violan
MBMaría Bodí
María Bodí
The mortality rate of chronic obstructive pulmonary disease (COPD) patients with community-acquired pneumonia (CAP) is reported to be low. However, studies carried out to date have included <20% of critically ill patients.The current authors performed a secondary analysis of a prospective study evaluating 428 immunocompetent patients admitted to the intensive care unit (ICU) for severe CAP.In total, 176 COPD patients were compared with 252 non-COPD patients. In COPD patients, ICU mortality (odds ratio (OR) 1.58; 95% confidence interval (CI) 1.01–1.43) and mechanical ventilation (OR 2.78; 95% CI 1.63–4.74) rates were higher than in non-COPD patients. The ICU mortality was 39% for COPD patients initially intubated and 50% for those who failed noninvasive ventilation. The proportion of patients who were males, aged ≥70 yrs, smokers and who had chronic heart disease orPseudomonas aeruginosawere higher in COPD patients. Inappropriate empirical antibiotic therapy was associated with higher mortality (OR 3.8; 95% CI 1.19–12.6). ICU mortality in COPD patients with adequate therapy was associated with bilateral pneumonia (OR 2.32; 95% CI 1.18–4.53) and shock (OR 3.53; 95% CI 1.31–9.71).In conclusion, chronic obstructive pulmonary disease patients hospitalised with community-acquired pneumonia in the intensive care unit had higher mortality and need of mechanical ventilation when compared with patients without chronic obstructive pulmonary disease.

1 July 1999 in Respiratory Medicine
Verified
Journal Article
Closed access
RORamon Orriols
Ramon Orriols
JRJ. Roig
J. Roig
JFJ. Ferrer
J. Ferrer
GSG. Sampol
G. Sampol
ARA. Rosell
A. Rosell
AFAntonio Vallano Ferraz
Antonio Vallano Ferraz

1 September 2005 in Chest
Verified
Journal Article
Closed access
PDF file
MSMiquel Sabrià
Miquel Sabrià
MPMaría Luisa Pedro-Botet
María Luisa Pedro-Botet
JGJoaquín Gómez
Joaquín Gómez
JRJorge Roig
Jorge Roig
BVBlanca Vilaseca
Blanca Vilaseca
VBVictor Baños
Victor Baños